BioMall
Brand Store/BDB Bioscience/BD PharmingenTM PE Mouse Anti-Mouse H-2Kb/SIINFEKL
B
GENERAL CATALOGUE

BD PharmingenTM PE Mouse Anti-Mouse H-2Kb/SIINFEKL

569792 · 25 ug

BDB Bioscience · Cat: 569792

₹90 – ₹130 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 569792
Category: reagents
Pack Size: 25 ug
Brand: BDB Bioscience

Description

Flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leucocytes were either not pulsed Left Panel or were pulsed Right Panel with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histograms or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; solid line histograms at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2Kb/SIINFEKL expression or Ig Isotype control expression were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry was performed using a BD LSRFortessa X-20 Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with prior SIINFEKL peptide treatment. Mouse splenic leucocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; Right Plot at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2Kb/SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leucocytes were either not pulsed Left Panel or were pulsed Right Panel with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histograms or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; solid line histograms at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2Kb/SIINFEKL expression or Ig Isotype control expression were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry was performed using a BD LSRFortessa X-20 Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific. Show More Multiparameter flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with prior SIINFEKL peptide treatment. Mouse splenic leucocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; Right Plot at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2Kb/SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leucocytes were either not pulsed Left Panel or were pulsed Right Panel with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histograms or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; solid line histograms at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2Kb/SIINFEKL expression or Ig Isotype control expression were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry was performed using a BD LSRFortessa X-20 Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2Kb/SIINFEKL expression on viable C57BL/6 Mouse splenic leucocytes with prior SIINFEKL peptide treatment. Mouse splenic leucocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or with PE Mouse Anti-Mouse H-2Kb/SIINFEKL antibody Cat. No. 569791/569792; Right Plot at 0.125 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2Kb/SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

B
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
B
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
B
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
B
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
B
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
B
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
B
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
B
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents